Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver PTX drug-eluting peripheral stent. [Review] 

<br/><br/>Available in print through MWHC library: 2002 - present 
<br/><br/> Zilver PTX (Cook Medical, Bloomington, IN) is a self-expanding nitinol drug-eluting stent with a polymer-free paclitaxel coating on its outer surface. The stent aims to provide improved treatment for patients with symptomatic peripheral arterial disease in the above-the-knee femoropopliteal arteries. On October 13, 2011, the Food and Drug Administration's (FDA) Circulatory System Devices Panel reviewed the Zilver PTX premarket approval application. This summary aims to describe the discussions and recommendations made during the meeting. Based on the Panel's recommendations, it is anticipated that the device will be approved by the FDA. Copyright  2012. Published by Elsevier Inc. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1878-0938 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Cardiovascular Agents/ad [Administration & Dosage]<br/>*Coated Materials, Biocompatible<br/>*Device Approval<br/>*Drug-Eluting Stents<br/>*Endovascular Procedures/is [Instrumentation]<br/>*Femoral Artery<br/>*Paclitaxel/ad [Administration & Dosage]<br/>*Peripheral Arterial Disease/th [Therapy]<br/>*Popliteal Artery<br/>*United States Food and Drug Administration<br/>Advisory Committees<br/>Alloys<br/>Constriction, Pathologic<br/>Endovascular Procedures/ae [Adverse Effects]<br/>Evidence-Based Medicine<br/>Humans<br/>Prosthesis Design<br/>Randomized Controlled Trials as Topic<br/>Registries<br/>Treatment Outcome<br/>United States
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article<br/>Review